Trade LGND anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Ligand Pharmaceuticals Incorporated (LGND) is trading at US$280.49, down 1.42% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$5.71B. Over the past 52 weeks, LGND has traded between US$160.80 and US$326.63. On Syfe you can trade LGND with $0 commission and add it to your watchlist.
| Previous close | US$284.52 |
|---|---|
| Market cap | US$5.71B |
| P/E ratio | 25.13 |
| 52-week range | US$160.80 – US$326.63 |
| Volume | 127.69K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Year: 1994
Ligand Pharmaceuticals Incorporated (LGND) stock is trading at US$280.49, -1.42% from the previous close of US$284.52.
The market cap for Ligand Pharmaceuticals Incorporated (LGND) stock is approximately US$5.71B.
The price-to-earnings ratio for Ligand Pharmaceuticals Incorporated (LGND) is 25.13, based on the latest reported earnings.
The 52-week high for Ligand Pharmaceuticals Incorporated (LGND) stock is US$326.63.
The 52-week low for Ligand Pharmaceuticals Incorporated (LGND) stock is US$160.80.
Ligand Pharmaceuticals Incorporated (LGND) does not currently pay a dividend.
Stay on top of LGND
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
